Gut microbiota: A player in aging and a target for anti-aging intervention

Ageing Research Reviews

Volumn 35, Issue , 2017, Pages 36-45

  Vaiserman, Alexander M ^a   Koliada, Alexander K ^a   Marotta, Francesco ^b  

^a INSTITUTE OF GERONTOLOGY   (Ukraine)

^b ReGenera Research Group for Aging Intervention   (Italy)

Author keywords

Age related disease; Aging; Gut microbiota; Healthspan; Lifespan; Probiotic

Indexed keywords

PROBIOTIC AGENT;

ADULT DISEASE; AGING; BACTEROIDES; BACTEROIDETES; BIFIDOBACTERIACEAE; CLOSTRIDIUM; CLOSTRIDIUM DIFFICILE INFECTION; DEGENERATIVE DISEASE; DETERIORATION; DIET; DIET THERAPY; ENTEROBACTER; ENTEROBACTERIACEAE; ENTEROCOCCUS; FAECALIBACTERIUM PRAUSNITZII; FECAL MICROBIOTA TRANSPLANTATION; FIRMICUTES; GERONTOLOGY; HOST; HUMAN; INTESTINE FLORA; LIFE EXPECTANCY; LIFE EXTENSION; LIFESTYLE; METABOLIC DISORDER; NONHUMAN; PROVIDENCIA; REVIEW; STAPHYLOCOCCUS; STREPTOCOCCUS; IMMUNOLOGY; INFLAMMATION; MULTIPLE CHRONIC CONDITIONS; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES;

AGING; DIET THERAPY; FECAL MICROBIOTA TRANSPLANTATION; GASTROINTESTINAL MICROBIOME; HUMANS; INFLAMMATION; MULTIPLE CHRONIC CONDITIONS;

EID: 85009973266     PISSN: 15681637     EISSN: 18729649     Source Type: Journal    
DOI: 10.1016/j.arr.2017.01.001     Document Type: Review

References (128)

1. Ananthaswamy, A., Faecal transplant eases symptoms of Parkinson's disease. New Sci. 209 (2011), 8–9.
2. Arboleya, S., Watkins, C., Stanton, C., Ross, R.P., Gut bifidobacteria populations in human health and aging. Front. Microbiol., 7, 2016, 1204.
3. Biagi, E., Nylund, L., Candela, M., Ostan, R., Bucci, L., Pini, E., Nikkïla, J., Monti, D., Satokari, R., Franceschi, C., Brigidi, P., De Vos, W., Through ageing, and beyond: gut microbiota and inflammatory status in seniors and centenarians. PLoS One, 5(5), 2010, e10667.
4. Biagi, E., Franceschi, C., Rampelli, S., Severgnini, M., Ostan, R., Turroni, S., Consolandi, C., Quercia, S., Scurti, M., Monti, D., Capri, M., Brigidi, P., Candela, M., Gut microbiota and extreme longevity. Curr. Biol. 26:11 (2016), 1480–1485.
5. Bischoff, S.C., Microbiota and aging. Curr. Opin. Clin. Nutr. Metab. Care 19:1 (2016), 26–30.
6. Boyle, R.J., Robins-Browne, R.M., Tang, M.L., Probiotic use in clinical practice: what are the risks?. Am. J. Clin. Nutr. 83:6 (2006), 1256–1264 (quiz 1446–1447).
7. Candela, M., Biagi, E., Brigidi, P., O'Toole, P.W., De Vos, W.M., Maintenance of a healthy trajectory of the intestinal microbiome during aging: a dietary approach. Mech. Ageing Dev. 136-137 (2014), 70–75.
8. Cattaneo, A., Cattane, N., Galluzzi, S., Provasi, S., Lopizzo, N., Festari, C., Ferrari, C., Guerra, U.P., Paghera, B., Muscio, C., Bianchetti, A., Volta, G.D., Turla, M., Cotelli, M.S., Gennuso, M., Prelle, A., Zanetti, O., Lussignoli, G., Mirabile, D., Bellandi, D., Gentile, S., Belotti, G., Villani, D., Harach, T., Bolmont, T., Padovani, A., Boccardi, M., Frisoni, G.B., INDIA-FBP Group, Association of brain amyloidosis with pro-inflammatory gut bacterial taxa and peripheral inflammation markers in cognitively impaired elderly. Neurobiol. Aging 49 (2017), 60–68.
9. Cerdá, B., Pérez, M., Pérez-Santiago, J.D., Tornero-Aguilera, J.F., González-Soltero, R., Larrosa, M., Gut microbiota modification: another piece in the puzzle of the benefits of physical exercise in health?. Front. Physiol., 7, 2016, 51.
10. Chen, Z., Guo, L., Zhang, Y., Walzem, R.L., Pendergast, J.S., Printz, R.L., Morris, L.C., Matafonova, E., Stien, X., Kang, L., Coulon, D., McGuinness, O.P., Niswender, K.D., Davies, S.S., Incorporation of therapeutically modified bacteria into gut microbiota inhibits obesity. J. Clin. Invest. 124:8 (2014), 3391–3406.
11. Choi, H.H., Cho, Y.S., Fecal microbiota transplantation: current applications, effectiveness, and future perspectives. Clin. Endosc. 49:3 (2016), 257–265.
12. Claesson, M.J., O'Sullivan, O., Wang, Q., Nikkila, J., Marchesi, J.R., Smidt, H., de Vos, W.M., Paul Ross, R., O'Toole, P.W., Comparative analysis of pyrosequencing and a phylogenetic microarray for exploring microbial community structures in the human distal intestine. PLoS One, 4(8), 2009, e6669.
13. Claesson, M.J., Cusack, S., O'Sullivan, O., Greene-Diniz, R., de Weerd, H., Flannery, E., Marchesi, J.R., Falush, D., Dinan, T., Fitzgerald, G., Stanton, C., van Sinderen, D., O'Connor, M., Harnedy, N., O'Connor, K., Henry, C., O'Mahony, D., Fitzgerald, A.P., Shanahan, F., Twomey, C., Hill, C., Ross, R.P., O'Toole, P.W., Composition, variability, and temporal stability of the intestinal microbiota of the elderly. Proc. Natl. Acad. Sci. U. S. A. 108:Suppl 1 (2011), 4586–4591.
14. Claesson, M.J., Jeffery, I.B., Conde, S., Power, S.E., O'Connor, E.M., Cusack, S., Harris, H.M., Coakley, M., Lakshminarayanan, B., O'Sullivan, O., Fitzgerald, G.F., Deane, J., O'Connor, M., Harnedy, N., O'Connor, K., O'Mahony, D., van Sinderen, D., Wallace, M., Brennan, L., Stanton, C., Marchesi, J.R., Fitzgerald, A.P., Shanahan, F., Hill, C., Ross, R.P., O'Toole, P.W., Gut microbiota composition correlates with diet and health in the elderly. Nature 488 (2012), 178–184.
15. Dąbrowska, K., Witkiewicz, W., Correlations of host genetics and gut microbiome composition. Front. Microbiol., 7, 2016, 1357.
16. Damms-Machado, A., Mitra, S., Schollenberger, A.E., Kramer, K.M., Meile, T., Königsrainer, A., Huson, D.H., Bischoff, S.C., Effects of surgical and dietary weight loss therapy for obesity on gut microbiota composition and nutrient absorption. Biomed. Res. Int., 2015, 2015, 806248.
17. Devkota, S., MICROBIOME. Prescription drugs obscure microbiome analyses. Science 351:6272 (2016), 452–453.
18. Dinan, T.G., Cryan, J.F., Gut instincts: microbiota as a key regulator of brain development, ageing and neurodegeneration. J. Physiol., 2016 in press.
19. Doron, S., Snydman, D.R., Risk and safety of probiotics. Clin. Infect. Dis. 60:Suppl 2 (2015), S129–S134.
20. Drago, L., Toscano, M., Rodighiero, V., de Vecchi, E., Mogna, G., Cultivable and pyrosequenced fecal microflora in centenarians and young subjects. J. Clin. Gastroenterol. 46 (2012), S81–S84.
21. Eloe-Fadrosh, E.A., Brady, A., Crabtree, J., Drabek, E.F., Ma, B., Mahurkar, A., Ravel, J., Haverkamp, M., Fiorino, A.M., Botelho, C., Andreyeva, I., Hibberd, P.L., Fraser, C.M., Functional dynamics of the gut microbiome in elderly people during probiotic consumption. MBio, 6(2), 2015 (pii: e00231-15).
22. Falkenberg, K.J., Johnstone, R.W., Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disorders. Nat. Rev. Drug Discov. 13:9 (2014), 673–691.
23. Felice, V.D., Quigley, E.M., Sullivan, A.M., O'Keeffe, G.W., O'Mahony, S.M., Microbiota-gut-brain signalling in Parkinson's disease: implications for non-motor symptoms. Parkinsonism Relat. Disord. 27 (2016), 1–8.
24. Friedland, R.P., Mechanisms of molecular mimicry involving the microbiota in neurodegeneration. J. Alzheimers Dis. 45:2 (2015), 349–362.
25. Gavini, F., Cayuela, C., Antoine, J.-M., Lecoq, C., Lefebvre, B., Membre, J.-M., Neut, C., Differences in the distribution of bifidobacterial and enterobacterial species in human faecal microflora of three different (children adults, elderly) age groups. Microb. Ecol. Health Dis. 13 (2001), 40–45.
26. Goulet, O., Potential role of the intestinal microbiota in programming health and disease. Nutr. Rev. 73:Suppl 1 (2015), 32–40.
27. Govindaraju, D., Atzmon, G., Barzilai, N., Genetics, lifestyle and longevity: lessons from centenarians. Appl. Transl. Genom. 4 (2015), 23–32.
28. Graham, C., Mullen, A., Whelan, K., Obesity and the gastrointestinal microbiota: a review of associations and mechanisms. Nutr. Rev. 73:6 (2015), 376–385.
29. Grompone, G., Martorell, P., Llopis, S., González, N., Genovés, S., Mulet, A.P., Fernández-Calero, T., Tiscornia, I., Bollati-Fogolín, M., Chambaud, I., Foligné, B., Montserrat, A., Ramón, D., Anti-inflammatory Lactobacillus rhamnosus CNCM I-3690 strain protects against oxidative stress and increases lifespan in Caenorhabditis elegans. PLoS One, 7(12), 2012, e52493.
30. Gupta, S., Allen-Vercoe, E., Petrof, E.O., Fecal microbiota transplantation: in perspective. Therap. Adv. Gastroenterol. 9:2 (2016), 229–239.
31. Gur, T.L., Bailey, M.T., Effects of stress on commensal microbes and immune system activity. Adv. Exp. Med. Biol. 874 (2016), 289–300.
32. Hébuterne, X., Gut changes attributed to ageing: effects on intestinal microflora. Curr. Opin. Clin. Nutr. Metab. Care 6:1 (2003), 49–54.
33. Haiser, H.J., Gootenberg, D.B., Chatman, K., Sirasani, G., Balskus, E.P., Turnbaugh, P.J., Predicting and manipulating cardiac drug inactivation by the human gut bacterium Eggerthella lenta. Science 341:6143 (2013), 295–298.
34. Hanson, M., The birth and future health of DOHaD. J. Dev. Orig. Health Dis. 6:5 (2015), 434–437.
35. Hartstra, A.V., Bouter, K.E., Bäckhed, F., Nieuwdorp, M., Insights into the role of the microbiome in obesity and type 2 diabetes. Diabetes Care 38:1 (2015), 159–165.
36. Hayashi, H., Sakamoto, M., Kitahara, M., Benno, Y., Molecular analysis of fecal microbiota in elderly individuals using 16S rDNA library and T-RFLP. Microbiol. Immunol., 47, 2003 557–557.
37. Honda, K., Littman, D.R., The microbiota in adaptive immune homeostasis and disease. Nature 535:7610 (2016), 75–84.
38. Hopkins, M.J., Macfarlane, G.T., Changes in predominant bacterial populations in human faeces with age and with Clostridium difficile infection. J. Med. Microbiol. 51 (2002), 448–454.
39. Hopkins, M.J., Sharp, R., Macfarlane, G.T., Variation in human intestinal microbiota with age. Dig. Liver Dis. 34:Suppl 2 (2002), S12–S18.
40. Hu, X., Wang, T., Jin, F., Alzheimer's disease and gut microbiota. Sci. China Life Sci. 59:10 (2016), 1006–1023.
41. Iqbal, S., Quigley, E.M., Progress in our understanding of the gut microbiome: implications for the clinician. Curr. Gastroenterol. Rep., 18(9), 2016, 49.
42. Jackson, M.A., Jeffery, I.B., Beaumont, M., Bell, J.T., Clark, A.G., Ley, R.E., O'Toole, P.W., Spector, T.D., Steves, C.J., Signatures of early frailty in the gut microbiota. Genome Med., 8(1), 2016, 8.
43. Janssen, A.W., Kersten, S., The role of the gut microbiota in metabolic health. FASEB J. 29:8 (2015), 3111–3123.
44. Jeffery, I.B., Lynch, D.B., O'Toole, P.W., Composition and temporal stability of the gut microbiota in older persons. ISME J. 10:1 (2016), 170–182.
45. Jeong, J.J., Kim, K.A., Hwang, Y.J., Han, M.J., Kim, D.H., Anti-inflammaging effects of Lactobacillus brevis OW38 in aged mice. Benef. Microbes. 7:5 (2016), 707–718.
46. John, G.K., Mullin, G.E., The gut microbiome and obesity. Curr. Oncol. Rep., 18(7), 2016, 45.
47. Jonkers, D.M., Microbial perturbations and modulation in conditions associated with malnutrition and malabsorption. Best. Pract. Res. Clin. Gastroenterol. 30:2 (2016), 161–172.
48. Jump, R.L., Clostridium difficile infection in older adults. Aging Health 9:4 (2013), 403–414.
49. Kashtanova, D.A., Popenko, A.S., Tkacheva, O.N., Tyakht, A.B., Alexeev, D.G., Boytsov, S.A., Association between the gut microbiota and diet: fetal life, early childhood, and further life. Nutrition 32:6 (2016), 620–627.
50. Keenan, M.J., Marco, M.L., Ingram, D.K., Martin, R.J., Improving healthspan via changes in gut microbiota and fermentation. Age (Dordr.), 37(5), 2015, 98.
51. Khan, S., Jena, G., The role of butyrate, a histone deacetylase inhibitor in diabetes mellitus: experimental evidence for therapeutic intervention. Epigenomics 7:4 (2015), 669–680.
52. Kim, H.M., Lee, D.E., Park, S.D., Kim, Y.T., Kim, Y.J., Jeong, J.W., Jang, S.S., Ahn, Y.T., Sim, J.H., Huh, C.S., Chung, D.K., Lee, J.H., Oral administration of Lactobacillus plantarum HY7714 protects hairless mouse against ultraviolet B-induced photoaging. J. Microbiol. Biotechnol. 24:11 (2014), 1583–1591.
53. Koleva, P.T., Kim, J.S., Scott, J.A., Kozyrskyj, A.L., Microbial programming of health and disease starts during fetal life. Birth Defects Res. C. Embryo Today 105:4 (2015), 265–277.
54. Komura, T., Ikeda, T., Yasui, C., Saeki, S., Nishikawa, Y., Mechanism underlying prolongevity induced by bifidobacteria in Caenorhabditis elegans. Biogerontology 14:1 (2013), 73–87.
55. Konturek, P.C., Haziri, D., Brzozowski, T., Hess, T., Heyman, S., Kwiecien, S., Konturek, S.J., Koziel, J., Emerging role of fecal microbiota therapy in the treatment of gastrointestinal and extra-gastrointestinal diseases. J. Physiol. Pharmacol. 66:4 (2015), 483–491.
56. Kristensen, N.B., Bryrup, T., Allin, K.H., Nielsen, T., Hansen, T.H., Pedersen, O., Alterations in fecal microbiota composition by probiotic supplementation in healthy adults: a systematic review of randomized controlled trials. Genome Med., 8(1), 2016, 52.
57. Kulecka, M., Paziewska, A., Zeber-Lubecka, N., Ambrozkiewicz, F., Kopczynski, M., Kuklinska, U., Pysniak, K., Gajewska, M., Mikula, M., Ostrowski, J., Prolonged transfer of feces from the lean mice modulates gut microbiota in obese mice. Nutr. Metab. (Lond.), 13(1), 2016, 57.
58. Kumar, M., Yadav, A.K., Verma, V., Singh, B., Mal, G., Nagpal, R., Hemalatha, R., Bioengineered probiotics as a new hope for health and diseases: an overview of potential and prospects. Future Microbiol. 11:4 (2016), 585–600.
59. Kwon, G., Lee, J., Lim, Y.H., Dairy Propionibacterium extends the mean lifespan of Caenorhabditis elegans via activation of the innate immune system. Sci. Rep., 6, 2016, 31713.
60. Lakshminarayanan, B., Stanton, C., O'Toole, P.W., Ross, R.P., Compositional dynamics of the human intestinal microbiota with aging: implications for health. J. Nutr. Health Aging 18:9 (2014), 773–786.
61. Lee, D.E., Huh, C.S., Ra, J., Choi, I.D., Jeong, J.W., Kim, S.H., Ryu, J.H., Seo, Y.K., Koh, J.S., Lee, J.H., Sim, J.H., Ahn, Y.T., Clinical evidence of effects of Lactobacillus plantarum HY7714 on skin aging: a randomized, double blind, placebo-controlled study. J. Microbiol Biotechnol. 25:12 (2015), 2160–2168.
62. Li, Y.T., Cai, H.F., Wang, Z.H., Xu, J., Fang, J.Y., Systematic review with meta-analysis: long-term outcomes of faecal microbiota transplantation for Clostridium difficile infection. Aliment. Pharmacol. Ther. 43:4 (2016), 445–457.
63. Lowry, C.A., Smith, D.G., Siebler, P.H., Schmidt, D., Stamper, C.E., Hassell, J.E. Jr., Yamashita, P.S., Fox, J.H., Reber, S.O., Brenner, L.A., Hoisington, A.J., Postolache, T.T., Kinney, K.A., Marciani, D., Hernandez, M., Hemmings, S.M., Malan-Muller, S., Wright, K.P., Knight, R., Raison, C.L., Rook, G.A., The microbiota, immunoregulation, and mental health: implications for public health. Curr. Environ. Health Rep. 3:3 (2016), 270–286.
64. Mäkivuokko, H., Tiihonen, K., Tynkkynen, S., Paulin, L., Rautonen, N., The effect of age and non-steroidal anti-inflammatory drugs on human intestinal microbiota composition. Br. J. Nutr. 103 (2010), 227–234.
65. Magnusson, K.R., Hauck, L., Jeffrey, B.M., Elias, V., Humphrey, A., Nath, R., Perrone, A., Bermudez, L.E., Relationships between diet-related changes in the gut microbiome and cognitive flexibility. Neuroscience 300 (2015), 128–140.
66. Mariat, D., Firmesse, O., Levenez, F., Guimarăes, V., Sokol, H., Doré, J., Corthier, G., Furet, J.P., The Firmicutes/Bacteroidetes ratio of the human microbiota changes with age. BMC Microbiol., 9, 2009, 123.
67. Mathur, R., Barlow, G.M., Obesity and the microbiome. Expert. Rev. Gastroenterol. Hepatol. 9:8 (2015), 1087–1099.
68. Matsumoto, M., Kurihara, S., Kibe, R., Ashida, H., Benno, Y., Longevity in mice is promoted by probiotic-induced suppression of colonic senescence dependent on upregulation of gut bacterial polyamine production. PLoS One, 6(8), 2011, e23652.
69. Maurice, C.F., Haiser, H.J., Turnbaugh, P.J., Xenobiotics shape the physiology and gene expression of the active human gut microbiome. Cell 152:1–2 (2013), 39–50.
70. Meehan, C.J., Langille, M.G., Beiko, R.G., Frailty and the microbiome. Interdiscip. Top. Gerontol. Geriatr. 41 (2015), 54–65.
71. Mueller, S., Saunier, K., Hanisch, C., Norin, E., Alm, L., Midtvedt, T., Cresci, A., Silvi, S., Orpianesi, C., Verdenelli, M.C., Clavel, T., Koebnick, C., Zunft, H.J.F., Doré, J., Blaut, M., Differences in fecal microbiota in different European study populations in relation to age, gender, and country: a cross-sectional study. Appl. Environ. Microbiol. 72 (2006), 1027–1033.
72. Mulak, A., Bonaz, B., Brain-gut-microbiota axis in Parkinson's disease. World J. Gastroenterol. 21:37 (2015), 10609–10620.
73. Nakagawa, H., Shiozaki, T., Kobatake, E., Hosoya, T., Moriya, T., Sakai, F., Taru, H., Miyazaki, T., Effects and mechanisms of prolongevity induced by Lactobacillus gasseri SBT2055 in Caenorhabditis elegans. Aging Cell 15:2 (2016), 227–236.
74. Nehra, V., Allen, J.M., Mailing, L.J., Kashyap, P.C., Woods, J.A., Gut microbiota: modulation of host physiology in obesity. Physiology (Bethesda) 31:5 (2016), 327–335.
75. O'Toole, P.W., Jeffery, I.B., Gut microbiota and aging. Science 350:6265 (2015), 1214–1215.
76. Pérez Martínez, G., Bäuerl, C., Collado, M.C., Understanding gut microbiota in elderly's health will enable intervention through probiotics. Benef. Microbes. 5:3 (2014), 235–246.
77. Park, M.R., Oh, S., Son, S.J., Park, D.J., Oh, S., Kim, S.H., Jeong, D.Y., Oh, N.S., Lee, Y., Song, M., Kim, Y., Bacillus licheniformis isolated from traditional Korean food resources enhances the longevity of Caenorhabditis elegans through serotonin signaling. J. Agric. Food Chem. 63:47 (2015), 10227–10233.
78. Park, S.H., Kim, K.A., Ahn, Y.T., Jeong, J.J., Huh, C.S., Kim, D.H., Comparative analysis of gut microbiota in elderly people of urbanized towns and longevity villages. BMC Microbiol., 15, 2015, 49.
79. Passarino, G., De Rango, F., Montesanto, A., Human longevity: genetics or Lifestyle? It takes two to tango. Immun. Ageing, 13, 2016, 12.
80. Patel, R., DuPont, H.L., New approaches for bacteriotherapy: prebiotics, new-generation probiotics, and synbiotics. Clin. Infect. Dis. 60:Suppl 2 (2015), S108–S121.
81. Paton, A.W., Morona, R., Paton, J.C., Bioengineered microbes in disease therapy. Trends Mol. Med. 18:7 (2012), 417–425.
82. Patrignani, P., Tacconelli, S., Bruno, A., Gut microbiota, host gene expression, and aging. J. Clin. Gastroenterol. 48:Suppl 1 (2014), S28–S31.
83. Paun, A., Danska, J.S., Modulation of type 1 and type 2 diabetes risk by the intestinal microbiome. Pediatr. Diabetes 17:7 (2016), 469–477.
84. Petrof, E.O., Gloor, G.B., Vanner, S.J., Weese, S.J., Carter, D., Daigneault, M.C., Brown, E.M., Schroeter, K., Allen-Vercoe, E., Stool substitute transplant therapy for the eradication of Clostridium difficile infection: ‘RePOOPulating’ the gut. Microbiome, 1, 2013, 3.
85. Pistollato, F., Sumalla Cano, S., Elio, I., Masias Vergara, M., Giampieri, F., Battino, M., Role of gut microbiota and nutrients in amyloid formation and pathogenesis of Alzheimer disease. Nutr. Rev. 74:10 (2016), 624–634.
86. Pope, J.L., Tomkovich, S., Yang, Y., Jobin, C., Microbiota as a mediator of cancer progression and therapy. Transl. Res. 179 (2017), 139–154.
87. Prenderville, J.A., Kennedy, P.J., Dinan, T.G., Cryan, J.F., Adding fuel to the fire: the impact of stress on the ageing brain. Trends Neurosci. 38:1 (2015), 13–25.
88. Ra, J., Lee, D.E., Kim, S.H., Jeong, J.W., Ku, H.K., Kim, T.Y., Choi, I.D., Jeung, W., Sim, J.H., Ahn, Y.T., Effect of oral administration of Lactobacillus plantarum HY7714 on epidermal hydration in ultraviolet B-irradiated hairless mice. J. Microbiol. Biotechnol. 24:12 (2014), 1736–1743.
89. Rajilic-Stojanovic, M., Heilig, H.G.H.J., Molenaar, D., Kajander, K., Surakka, A., Smidt, H., de Vos, W.M., Development and application of the Human Intestinal Tract Chip: a phylogenetic microarray: analysis of the universally conserved phylotypes in the abundant microbiota of young and elderly adults. Environ. Microbiol. 11 (2009), 1736–1751.
90. Rampelli, S., Candela, M., Turroni, S., Biagi, E., Collino, S., Franceschi, C., O'Toole, P.W., Brigidi, P., Functional metagenomic profiling of intestinal microbiome in extreme ageing. Aging (Albany, NY) 5:12 (2013), 902–912.
91. Rao, K., Safdar, N., Fecal microbiota transplantation for the treatment of Clostridium difficile infection. J. Hosp. Med. 11:1 (2016), 56–61.
92. Rehman, T., Role of the gut microbiota in age-related chronic inflammation. Endocr. Metab. Immune Disord. Drug Targets 12:4 (2012), 361–367.
93. Remely, M., Tesar, I., Hippe, B., Gnauer, S., Rust, P., Haslberger, A.G., Gut microbiota composition correlates with changes in body fat content due to weight loss. Benef. Microbes. 6:4 (2015), 431–439.
94. Ridaura, V.K., Faith, J.J., Rey, F.E., Cheng, J., Duncan, A.E., Kau, A.L., Griffin, N.W., Lombard, V., Henrissat, B., Bain, J.R., Muehlbauer, M.J., Ilkayeva, O., Semenkovich, C.F., Funai, K., Hayashi, D.K., Lyle, B.J., Martini, M.C., Ursell, L.K., Clemente, J.C., Van Treuren, W., Walters, W.A., Knight, R., Newgard, C.B., Heath, A.C., Gordon, J.I., Gut microbiota from twins discordant for obesity modulate metabolism in mice. Science, 341(6150), 2013, 1241214.
95. Rivière, A., Selak, M., Lantin, D., Leroy, F., De Vuyst, L., Bifidobacteria and butyrate-producing colon bacteria: importance and strategies for their stimulation in the human gut. Front. Microbiol., 7, 2016, 979.
96. Rodríguez, J.M., Murphy, K., Stanton, C., Ross, R.P., Kober, O.I., Juge, N., Avershina, E., Rudi, K., Narbad, A., Jenmalm, M.C., Marchesi, J.R., Collado, M.C., The composition of the gut microbiota throughout life, with an emphasis on early life. Microb. Ecol. Health Dis., 26, 2015, 26050.
97. Rondanelli, M., Giacosa, A., Faliva, M.A., Perna, S., Allieri, F., Castellazzi, A.M., Review on microbiota and effectiveness of probiotics use in older. World J. Clin. Cases 3:2 (2015), 156–162.
98. Sánchez, B., Delgado, S., Blanco-Míguez, A., Lourenço, A., Gueimonde, M., Margolles, A., Probiotics, gut microbiota and their influence on host health and disease. Mol. Nutr. Food Res., 2016 (in press).
99. Saad, M.J., Santos, A., Prada, P.O., Linking gut microbiota and inflammation to obesity and insulin resistance. Physiology (Bethesda) 31:4 (2016), 283–293.
100. Sampson, T.R., Debelius, J.W., Thron, T., Janssen, S., Shastri, G.G., Ilhan, Z.E., Challis, C., Schretter, C.E., Rocha, S., Gradinaru, V., Chesselet, M.F., Keshavarzian, A., Shannon, K.M., Krajmalnik-Brown, R., Wittung-Stafshede, P., Knight, R., Mazmanian, S.K., Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson's disease. Cell 167:6 (2016), 1469–1480 (e12).
101. Sanders, M.E., Probiotics and microbiota composition. BMC Med., 14(1), 2016, 82.
102. Sandhu, K.V., Sherwin, E., Schellekens, H., Stanton, C., Dinan, T.G., Cryan, J.F., Feeding the microbiota-gut-brain axis: diet, microbiome, and neuropsychiatry. Transl. Res. 179 (2017), 223–244.
103. Sanduzzi Zamparelli, M., Compare, D., Coccoli, P., Rocco, A., Nardone, O.M., Marrone, G., Gasbarrini, A., Grieco, A., Nardone, G., Miele, L., The metabolic role of gut microbiota in the development of nonalcoholic fatty liver disease and cardiovascular disease. Int. J. Mol. Sci., 17(8), 2016 (pii: E1225).
104. Saraswati, S., Sitaraman, R., Aging and the human gut microbiota-from correlation to causality. Front. Microbiol., 5, 2015, 764.
105. Satoh, T., Murata, M., Iwabuchi, N., Odamaki, T., Wakabayashi, H., Yamauchi, K., Abe, F., Xiao, J.Z., Effect of Bifidobacterium breve B-3 on skin photoaging induced by chronic UV irradiation in mice. Benef. Microbes 6:4 (2015), 497–504.
106. Satokari, R., Mattila, E., Kainulainen, V., Arkkila, P.E., Simple faecal preparation and efficacy of frozen inoculum in faecal microbiota transplantation for recurrent Clostridium difficile infection: an observational cohort study. Aliment. Pharmacol. Ther. 41 (2015), 46–53.
107. Shen, Q., Shang, N., Li, P., In vitro and in vivo antioxidant activity of Bifidobacterium animalis 01 isolated from centenarians. Curr. Microbiol. 62:4 (2011), 1097–1103.
108. Shin, J.H., High, K.P., Warren, C.A., Older is not wiser, immunologically speaking: effect of aging on host response to clostridium difficile infections. J. Gerontol. A Biol. Sci. Med. Sci. 71:7 (2016), 916–922.
109. Steidler, L., Genetically engineered probiotics. Best Pract. Res. Clin. Gastroenterol. 17:5 (2003), 861–876.
110. Thushara, R.M., Gangadaran, S., Solati, Z., Moghadasian, M.H., Cardiovascular benefits of probiotics: a review of experimental and clinical studies. Food Funct. 7:2 (2016), 632–642.
111. Tojo, R., Suárez, A., Clemente, M.G., de los Reyes-Gavilán, C.G., Margolles, A., Gueimonde, M., Ruas-Madiedo, P., Intestinal microbiota in health and disease: role of bifidobacteria in gut homeostasis. World J. Gastroenterol. 20:41 (2014), 15163–15176.
112. Udayappan, S.D., Hartstra, A.V., Dallinga-Thie, G.M., Nieuwdorp, M., Intestinal microbiota and faecal transplantation as treatment modality for insulin resistance and type 2 diabetes mellitus. Clin. Exp. Immunol. 177:1 (2014), 24–29.
113. Vaiserman, A.M., Pasyukova, E.G., Epigenetic drugs: a novel anti-aging strategy?. Front. Genet., 3, 2012, 224.
114. van Nood, E., Vrieze, A., Nieuwdorp, M., Fuentes, S., Zoetendal, E.G., de Vos, W.M., Visser, C.E., Kuijper, E.J., Bartelsman, J.F., Tijssen, J.G., Speelman, P., Dijkgraaf, M.G., Keller, J.J., Duodenal infusion of donor feces for recurrent Clostridium difficile. N. Engl. J. Med. 368 (2013), 407–415.
115. Vrieze, A., Van Nood, E., Holleman, F., Salojärvi, J., Kootte, R.S., Bartelsman, J.F., Dallinga-Thie, G.M., Ackermans, M.T., Serlie, M.J., Oozeer, R., Derrien, M., Druesne, A., Van Hylckama Vlieg, J.E., Bloks, V.W., Groen, A.K., Heilig, H.G., Zoetendal, E.G., Stroes, E.S., de Vos, W.M., Hoekstra, J.B., Nieuwdorp, M., Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome. Gastroenterology 143:4 (2012), 913–916 (e7).
116. Vyas, D., Aekka, A., Vyas, A., Fecal transplant policy and legislation. World J. Gastroenterol. 21:1 (2015), 6–11.
117. Wallace, J.G., Gohir, W., Sloboda, D.M., The impact of early life gut colonization on metabolic and obesogenic outcomes: what have animal models shown us?. J. Dev Orig. Health Dis. 7:1 (2016), 15–24.
118. Woodmansey, E.J., McMurdo, M.E.T., Macfarlane, C.T., Macfarlane, S., Comparison of compositions and metabolic activities of fecal microbiotas in young adults and in antibiotic-treated and non-antibiotic treated elderly subjects. Appl. Environ. Microbiol. 70 (2004), 6113–6122.
119. Xu, R., Shang, N., Li, P., In vitro and in vivo antioxidant activity of exopolysaccharide fractions from Bifidobacterium animalis RH. Anaerobe 17:5 (2011), 226–231.
120. Xu, M.Q., Cao, H.L., Wang, W.Q., Wang, S., Cao, X.C., Yan, F., Wang, B.M., Fecal microbiota transplantation broadening its application beyond intestinal disorders. World J. Gastroenterol. 21:1 (2015), 102–111.
121. Yang, H.Y., Liu, S.L., Ibrahim, S.A., Zhao, L., Jiang, J.L., Sun, W.F., Ren, F.Z., Oral administration of live Bifidobacterium substrains isolated from healthy centenarians enhanced immune function in BALB/c mice. Nutr. Res. 29:4 (2009), 281–289.
122. Yang, H., Liu, A., Zhang, M., Ibrahim, S.A., Pang, Z., Leng, X., Ren, F., Oral administration of live Bifidobacterium substrains isolated from centenarians enhances intestinal function in mice. Curr. Microbiol. 59:4 (2009), 439–445.
123. Young, V.B., Hayden, M.K., Environmental management in the gut: fecal transplantation to restore the intestinal ecosystem. Infect. Dis. (Lond.) 48:8 (2016), 593–595.
124. Youngster, I., Sauk, J., Pindar, C., Wilson, R.G., Kaplan, J.L., Smith, M.B., Alm, E.J., Gevers, D., Russell, G.H., Hohmann, E.L., Fecal microbiota transplant for relapsing Clostridium difficile infection using a frozen inoculum from unrelated donors: a randomized, open-label, controlled pilot study. Clin. Infect. Dis. 58:11 (2014), 1515–1522.
125. Youngster, I., Russell, G.H., Pindar, C., Ziv-Baran, T., Sauk, J., Hohmann, E.L., Oral, capsulized, frozen fecal microbiota transplantation for relapsing Clostridium difficile infection. JAMA 312 (2014), 1772–1778.
126. Zhang, C., Li, S., Yang, L., Huang, P., Li, W., Wang, S., Zhao, G., Zhang, M., Pang, X., Yan, Z., Liu, Y., Zhao, L., Structural modulation of gut microbiota in life-long calorie-restricted mice. Nat. Commun., 4, 2013, 2163.
127. Zhang, X., Zheng, X., Yuan, Y., Treatment of insulin resistance: straight from the gut. Drug Discov. Today 21:8 (2016), 1284–1290.
128. Zwielehner, J., Liszt, K., Handschur, M., Lassl, C., Lapin, A., Haslberger, A.G., Combined PCR-DGGE fingerprinting and quantitative-PCR indicates shifts in fecal population sizes and diversity of Bacteroides, bifidobacteria and Clostridium cluster IV in institutionalized elderly. Exp. Gerontol. 44 (2009), 440–446.